Galangin mitigates letrozole-induced polycystic ovary syndrome in rats by restoring PI3K/pAKT/PTEN signaling

Key Points

• Galangin significantly reduces the severity of polycystic ovary syndrome in the rat model, restoring normal ovary function.
• The PI3K/AKT/PTEN signaling pathway shows notable improvement with treatment, indicating effective intervention.
• Experimental analysis using letrozole-induced rats highlights the potential role of galangin as a therapeutic agent.
• Further exploration is needed on galangin's effectiveness in larger, diverse populations to confirm these results.